
ÜTS Individual Movement Notifications: Production, Import, Transfer
ÜTS individual movement notifications: the production and import notification, placing on the market, transfer to the distributor, sale and delivery, and the use stage, and who keeps the record at each.
You have a list of individual item movements; you have heard names such as purchase, consumption and return, but nobody explains, with article references, which provision each one rests on, what information it makes mandatory and at what moment it has to be made. In an inspection, the answer "that is how it was written in the system" does not work.
This page takes up the movements a device goes through over its life in sequence, on the basis of the events the legislation actually names: manufacture and import, placing on the market, linking between packaging levels, transfer to a distributor, sale and delivery, putting into service and use, implantation, return, recall, repackaging, reprocessing, supply interruption and closing the record. Under each heading the legal counterpart of the event is given first, and then the record that event makes mandatory. What the individual item is and how the barcode is determined is not the subject of this page; you will find that on the ÜTS individual item notifications page.
The sources are the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği) published in the Official Gazette No. 31499 (bis) of 2/6/2021, the Medical Device Sales, Advertising and Promotion Regulation (Tıbbi Cihaz Satış, Reklam ve Tanıtım Yönetmeliği) published in the Official Gazette No. 29001 of 15/5/2014, and the Manual on Registration Procedures of Medical Devices in the Product Tracking System (Tıbbi Cihazların Ürün Takip Sistemine Kayıt Süreçlerine İlişkin Kılavuz).
The sources do not give a list of movement types; read this knowingly
It has to be said at the outset: none of these three texts names, one by one, the types of individual item movement notification on the ÜTS screen. Article 4(1)(t) of the Sales, Advertising and Promotion Regulation defines the individual item notification as all movement notifications that must be made through the Product Tracking System from the moment medical devices are manufactured or imported, and stops there. It does not give a list; it draws a scope.
For this reason the movements have to be derived from the events the legislation names. If you are looking for the basis of a movement notification, first find the legal event to which that movement corresponds; the obligation and the record to be kept are there. The headings below are arranged on this logic. Where the source is silent, we stay silent and do not guess.
Manufacture and import: the moment the clock starts
The obligation starts not with the sale but with the existence of the product. Article 4(1)(t) of the Sales, Advertising and Promotion Regulation sets the starting moment as manufacture or import.
On the import side there are verifications to be made before this moment. Article 13(2)(a) of the Medical Device Regulation says that, in order to place a device on the market, the importer will verify that the device is CE marked and that the EU declaration of conformity has been drawn up, that the manufacturer is identified and, where required, an authorised representative has been appointed, that the device is labelled in accordance with the Regulation and that the required instructions for use accompany the device, and, where required, that a UDI has been assigned by the manufacturer in accordance with Article 27. Sub-point (4) is the key point here: trying to set up an individual item record for a device without a UDI is the consequence of an import that should not have been made in the first place.
Paragraph 4 of the same article states that the importer will verify that the device has been registered in the electronic system in accordance with Article 29 and will add its own details to the registration in accordance with Article 31. Article 30(2) of the same Regulation sets a time limit for this verification: importers verify, within 2 weeks of placing a device on the market (other than a custom-made device), that the manufacturer or the authorised representative has entered the relevant information in the electronic system; if the information is missing or incorrect, they inform the authorised representative or the manufacturer.
The storage condition is also an obligation at this first stage. Article 13(5) of the same Regulation requires the importer to ensure that, while the device is under their responsibility, storage or transport conditions do not jeopardise its compliance with the general safety and performance requirements set out in Annex I.
Placing on the market, making available on the market and putting into service are three separate events
These three terms are used interchangeably in everyday speech; in the legislation all three are defined separately and they point to separate moments.
Article 4(1)(s) of the Sales, Advertising and Promotion Regulation defines placing on the market as the first making available of a device on the market, other than devices intended for investigation. Point (ş) of the same paragraph defines making available on the market as the supply of a device that has been placed on the market, through a commercial activity, with or without charge, for distribution, consumption or use. Point (y) of the same paragraph defines putting into service as the stage at which a device is made ready, in accordance with its intended purpose, for the end user for the first time on the Turkish market.
The practical result is this: placing on the market happens once, making available on the market happens again and again, and putting into service is the moment the device enters use. In the movement history of a device these three should appear separately; if they are recorded as the same event, the middle of the chain is lost.
The transition between packaging levels is not a movement but a linking
A common mistake is trying to record the carton as a separate individual item. Article 27(2)(b)(6) of the Manual says that the device record is made in ÜTS essentially with the barcode of the smallest package placed on the market, and that the barcodes of multi-product sales packages are added, with their content quantities, to the "Placing on the Market Information" ("Piyasaya Arz Bilgisi") field after the device record is completed. Article 36(1) of the Manual describes the same operation as linking, one by one, the barcodes of boxes, packages and containers holding multiple products to the individual product barcode.
The boundary on the label side is drawn as well. Article 27(4) of the Medical Device Regulation states that UDI carriers will be placed on the label of the device and on all higher levels of packaging, but that higher levels of packaging do not include shipping containers. A shipping container does not carry a UDI; therefore an individual item movement cannot be set up on the basis of a shipping container.
Transfer to a distributor: the verification list is a precondition of the movement
Handing a device to a distributor requires the distributor to carry out their own verification. Article 14(2)(a) of the Medical Device Regulation says that, before making a device available on the market, the distributor will verify that the device is CE marked and that the EU declaration of conformity has been drawn up, that the information supplied by the manufacturer in accordance with Article 10(11) accompanies the device, that, for imported devices, the importer has complied with the requirements in Article 13(3), and, where required, that a UDI has been assigned by the manufacturer.
Point (b) of the same paragraph grants a flexibility: in order to meet the requirements in sub-points 1, 2 and 4 of this point, the distributor may apply a sampling method representative of the devices supplied by them. This flexibility is only for the verification method; it is not for the record itself.
Paragraph 3 of the same article requires the distributor to ensure that, while the device is under their responsibility, storage or transport conditions comply with the conditions set by the manufacturer. Article 8(1) of the Sales, Advertising and Promotion Regulation also says that devices are kept under the conditions set by their manufacturer and required by international standards. If there is no record behind a transfer movement that these conditions were met, the movement is incomplete.
Sale and delivery: the warranty certificate must carry the barcode
The most concrete written counterpart of the sale movement is the warranty certificate. Article 25/C(1)(e) of the Sales, Advertising and Promotion Regulation makes it mandatory that the warranty certificate given to the healthcare service provider contains, at a minimum, the product name, brand, version/model, product barcode number and LOT/serial number of the device as they appear in the Agency's electronic registration system. Point (f) of the same paragraph makes the date and place of delivery of the device to the healthcare service provider mandatory, and point (d) the date and number of the invoice.
This point alone shows which fields your individual item movement record must carry at the moment of sale: the barcode and LOT/serial number in ÜTS, the delivery date, the delivery place and the invoice information. Article 25/B(1) of the same Regulation says that the warranty period starts from the date of the invoice issued after the healthcare service provider accepts the device; that is, the delivery and invoice dates produce legal consequences afterwards as well.
Article 25/A(2) of the same Regulation states that the warranty certificate issued is given to the healthcare service provider, and that the burden of proving that this obligation has been fulfilled lies with the sales centre. Since the burden of proof is on you, the record of the delivery movement should also be kept with you.
The two prohibitions ahead of a sale should also be remembered: Article 26(2) of the same Regulation prohibits the sale of a device that is not registered in the registration and information management system, and paragraph 7 prohibits the sale of devices other than those in Annex-3 to places that are not registered in the system, except for the places specified in the manual.
Putting into service and use: who keeps the record
When a device passes to a healthcare institution, the recording obligation shifts as well. Article 27(9)(a) of the Medical Device Regulation says that healthcare institutions will record and keep, preferably by electronic means, the UDIs of the devices they have supplied or that have been supplied to them, if these devices are among Class III implantable devices.
Point (b) of the same paragraph states that, for devices other than Class III implantable devices, healthcare institutions are encouraged to record and keep the UDIs of the devices supplied to them, and that this may be requested when deemed necessary; point (c) states that the same encouragement applies to healthcare professionals. The source draws a clear line here between obligation and encouragement, and this line should not be erased: for devices other than Class III implantable devices, the healthcare institution's UDI record is written in the text of the Regulation not as an obligation but as encouragement and as something that may be requested.
Implantation: the information that goes to the patient is also a record
Implantation is the moment the movement is tied to the patient, and it gives rise to a separate document. Article 18(1)(a) of the Medical Device Regulation says that the manufacturer of an implantable device will provide with the device the name, address and website of the manufacturer together with the information that allows the device to be identified, including the device name, serial number, lot number, UDI and device model. Point (c) of the same paragraph brings information on the expected lifetime of the device and the necessary follow-up into this scope.
Paragraph 2 of the same article says that this information will be provided in Turkish and, where necessary, in English, in a way that allows quick access by the patient, and that manufacturers will provide the information in point (a) of paragraph 1 on an implant card supplied with the device. Paragraph 3 of the same article says that healthcare institutions will make this information available, together with the implant card carrying the identification information, to patients in whom the device has been implanted.
There is also an exemption. Paragraph 4 of the same article exempts sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors from the obligations in this article. This exemption relates to the implant card obligation; the source does not say that it removes the other recording obligations for the devices in question.
Return and halting sales: the triggering event is the Agency's announcement
The clearest written form of the return movement is the unsafe product case. Article 31(2) of the Sales, Advertising and Promotion Regulation says that sales centres are obliged, for devices found to be unsafe or non-compliant with technical regulations within the scope of market surveillance and inspection and the warning system and announced by the Agency, to stop the sale of these devices immediately, return them to the manufacturer or importer, and, upon request, share with the Agency all kinds of information and documents relating to the firm, the user and the activities carried out on the matter concerning the device sold.
This paragraph gathers three separate movements into one sentence: stopping the sale, returning the device backwards, and submitting user-level information to the Agency. The third can be done only if your individual item record goes down to the user level. Article 29(1)(e) of the same Regulation states that, if Article 31(2) is violated, the activity of the sales centre will be temporarily suspended for fifteen days.
Paragraph 1 of Article 31 of the same Regulation also establishes a separate notification obligation: sales centres promptly notify the Agency and the manufacturer or importer of the device concerned of adverse events they come across during their activities relating to their own devices or other devices.
Withdrawal and recall: the chain operating in reverse
A recall is the real test of a movement record, because it requires a record kept forwards to be read backwards.
Article 10(12) of the Medical Device Regulation says that manufacturers who consider that a device they have placed on the market or put into service does not conform to the Regulation will promptly take the appropriate corrective action, such as bringing the device into conformity, withdrawing it or recalling it, and will inform their distributors and, where applicable, their authorised representative and importers. Article 13(7) of the same Regulation ties the same obligation to the importer, and Article 14(4) to the distributor.
The record-keeping obligation is also expressly written here. Article 13(6) of the same Regulation says that importers will keep a register of complaints, non-conforming devices, recalls and withdrawals; Article 14(5) places the same record-keeping obligation on the distributor.
The function of the UDI at this stage is also written in the Regulation. Article 27(5) of the same Regulation states that the UDI will be used to report serious adverse events and field safety corrective actions in accordance with Article 85. Article 85(8) of the same Regulation says that the manufacturer will report a field safety corrective action without delay before carrying it out, except in urgent cases where it must carry out the field safety corrective action promptly.
Relabelling and repackaging: 28-day prior notification
Some movements touch the identity of the product, and then a separate procedure comes into play. Article 16(2)(a) of the Medical Device Regulation does not count as a modification that may affect conformity the provision, in respect of a device already placed on the market, of the information supplied by the manufacturer, including translation; and point (b) does not count changes to the outer packaging, including a change of pack size, if the repackaging is necessary for marketing the device and is carried out in such conditions that the original condition is not affected.
However, these activities are not free either. Paragraph 3 of the same article says that the distributor or importer carrying out these activities will indicate, on the device or, where that is not practicable, on its packaging or in a document accompanying the device, together with the activity carried out, its name, registered trade name or trade mark and address. Paragraph 5 of the same article sets a time limit: at least 28 days before the relabelled or repackaged device is made available on the market, the manufacturer and the Agency are informed of the intention to make the device in question available; within the same 28-day period, a certificate issued by a designated notified body, confirming that the quality management system complies with the requirements in paragraphs 3 and 4, is submitted to the Agency.
The other side of the boundary is heavier. Points (a), (b) and (c) of paragraph 1 of the same article say that the person concerned takes on the obligations incumbent on manufacturers where they make a device available on the market under their own name or trade mark, change the intended purpose of a device already placed on the market, or modify a device in such a way that conformity may be affected. In that case it is no longer a movement notification that is under discussion, but a new device record.
Reprocessing: the device changes identity
Reprocessing a single-use device breaks the movement chain and starts a new one. Article 17(2) of the Medical Device Regulation says that a person who reprocesses a single-use device to make it suitable for further use will be considered the manufacturer of the reprocessed device and will assume the obligations incumbent on manufacturers, including the obligations relating to the traceability of the reprocessed device under Part Three of the Regulation.
The label changes as well. Paragraph 8 of the same article says that the name and address of the reprocessor and the other relevant information in point 23 of Annex I will be indicated on the label of the reprocessed device and, if applicable, in its instructions for use; the name and address of the manufacturer of the original single-use device will no longer appear on the label, but will be indicated in the instructions for use of the reprocessed device. Paragraph 6 of the same article says that only single-use devices that have been placed on the market in accordance with this Regulation, or in accordance with the Medical Device Regulation repealed before 26/5/2021, may be reprocessed.
The result for the record is clear: the reprocessed product is not a continuation of the movement history under the previous barcode.
Supply interruption: the stopping of a movement is also notified
The absence of a movement is an event too. Article 10/A(1)(a) of the Medical Device Regulation says that where a manufacturer foresees an interruption or discontinuation in the supply of a device other than a custom-made device, and it can reasonably be foreseen that this may result in serious harm or a risk of serious harm to patients or public health, the manufacturer will inform the Agency, and also the economic operators, healthcare institutions and healthcare professionals to which it directly supplies the device.
Point (b) of the same paragraph sets the time: except in exceptional circumstances, this information is provided at least six months before the foreseen interruption or discontinuation, and the manufacturer clearly states the reasons for the interruption or discontinuation in the information provided to the Agency. Paragraph 3 of the same article continues the chain: economic operators who receive the information inform without delay the other economic operators, healthcare institutions and healthcare professionals to which they directly supply the device about the foreseen interruption or discontinuation.
Identifying the recipients of this information as those "to which they directly supply" is possible only if your chain record is up to date.
Closing a record does not mean deleting it on the ÜTS side
When you remove a product from your portfolio you want to delete its ÜTS record; the system does not always allow this. Article 34(6) of the Manual says that the device records requested to be deleted must be in "Draft" ("Taslak"), "Ready for Application" ("Başvuruya Hazır"), "Registered" ("Kayıtlı") or "Rejected" ("Reddedildi") status. Paragraph 7 of the same article says that records in "Draft" and "Ready for Application" status will be deleted from ÜTS; paragraph 8 says that records in "Registered" status and in "Rejected" status, other than certain rejection decisions, are not deleted but are brought to "Deleted" ("Silindi") status.
Paragraph 9 of the same article says that device records can be deleted only by the firm concerned and that no device record deletion is carried out by the Agency. Paragraph 4 of the same article says that the primary product numbers of the devices to be deleted and the reasons for deletion are entered in the bulk deletion file. The reason is a mandatory field; closing a record is also a notification.
Which field you will look for in which movement
The practical summary of the headings above is this:
Manufacture and import: the existence of the UDI assignment, verification of the electronic system record, and the storage condition record; Article 13(2), (4) and (5) of the Medical Device Regulation.
Sale and delivery: the barcode in ÜTS, LOT/serial number, delivery date and place, invoice date and number; Article 25/C(1)(d), (e) and (f) of the Sales, Advertising and Promotion Regulation.
Implantation: serial number, lot number, UDI and device model; Article 18(1)(a) of the Medical Device Regulation.
Return and halting sales: the firm that purchased the device and user-level information; Article 31(2) of the Sales, Advertising and Promotion Regulation.
Recall and withdrawal: records of complaints, non-conforming devices, recalls and withdrawals; Article 13(6) and Article 14(5) of the Medical Device Regulation.
Repackaging: the name and address of the person carrying out the activity and the 28-day prior notification; Article 16(3) and (5) of the Medical Device Regulation.
What we do in movement notifications, and what the firm does
Within medical device ÜTS registration consultancy, the outputs we produce on the movement side are these:
Event-obligation mapping: We match, at article and paragraph level, each physical event in your workflow with the provision of the legislation it corresponds to.
Field list: For each movement we write the minimum fields that must be present in your record, derived from the points cited above.
Recall rehearsal: With the record you have, we try to read backwards how many units of a given lot went to which healthcare institution, and we report the places that cannot be read.
Warranty certificate check: We check whether the warranty certificate template you use carries the minimum information in Article 25/C(1), in particular the ÜTS barcode and the LOT/serial number.
Barcode break plan: In situations that change identity, such as repackaging, a change in content quantity or reprocessing, we write in advance where the movement history will be cut.
What we cannot do is clear as well. We cannot carry out the movement itself; the party that knows where the device is is you, and under Article 31(4) of the Sales, Advertising and Promotion Regulation the accuracy of the information recorded in the system belongs to the firm that makes the record. Stopping sales and carrying out the return in the case of an unsafety announced by the Agency is the sales centre's obligation under Article 31(2) of the same Regulation. Reporting serious adverse events and field safety corrective actions is the manufacturer's obligation under Article 85 of the Medical Device Regulation, and the consultant cannot submit this report on the manufacturer's behalf. The notification of a supply interruption is also placed on the manufacturer by Article 10/A(1) of the same Regulation.
Our way of working is as in the other headings: the firm opens a user authorisation for the consultant from the ÜTS firm page, the records are created with the "Medical Device Registration Operator" ("Tıbbi Cihaz Kayıt Elemanı") authorisation, and the person who electronically signs the application remains the firm's signatory.
